Introduction {#s1}
============

In the course of using stopped-flow (SF) absorbance spectroscopy to study the effects of inhibitors or the genetic disruption of membrane proteins on the efflux of oxygen (O~2~) from red blood cells (RBCs), we suspected that RBCs were hemolyzing in the SF reaction cell, thereby releasing hemoglobin (Hb) and leading to overestimates of the rate constants for O~2~ efflux. Moreover, different degrees of hemolysis under different experimental conditions could lead to different extents of overestimation. In our work, the computed percent hemolysis (%*H*) of RBC samples entering the SF device is far too low to influence our results appreciably, whereas the %*H* of material that eventually exits the SF device---this may occur many minutes after a single SF experiment or "shot"---is far too high to be consistent with our O~2~-efflux data. We therefore set out to develop an assay that could report %*H* within the SF reaction cell, and do so in a time domain similar to that of our O~2~-efflux experiments. Because we are concerned with Hb in the bulk extracellular fluid (BECF), we devise an assay that: \[a\] measures a BECF parameter; \[b\] uses, as far as possible, physiological reactants and products; and targets a substance that \[c\] is normally present exclusively in the RBC cytosol (i.e., not normally exposed to the BECF compartment) but \[d\] would---upon hemolysis---enter the BECF with the same time course as Hb. Two substances that fit this criterion are the high-abundance/low-activity enzyme carbonic anhydrase (CA) I and the low-abundance/high-activity CA II (Khalifah, [@B29]; Dodgson et al., [@B11]; Sly and Hu, [@B47]).

Since the discovery of CA by Meldrum and Roughton ([@B34]), investigators have used several approaches for assaying the activity of this enzyme. Virtually simultaneously, Meldrum and Roughton introduced a manometric CA assay (Meldrum and Roughton, [@B34]), Brinkman introduced a colorimetric variant (Brinkman, [@B6]), and Stadie and O\'Brien introduced an electrometric approach based on a platinum pH electrode (Stadie and O\'Brien, [@B48]). In 1948, Wilbur and Anderson replaced platinum with a glass pH electrode (Wilbur and Anderson, [@B53]). All of these approaches are intrinsically slow and thus require that the preparation be a low temperature (0°C). After the introduction of stopped-flow devices by Chance in 1950 (Chance, [@B7]), several investigators used stopped-flow absorbance or fluorescence spectroscopy to study the kinetics of CA (Gibbons and Edsall, [@B12], [@B13]; Ho and Sturtevant, [@B18]; Kernohan, [@B26], [@B27]; Khalifah, [@B29]; Wistrand et al., [@B54]; Pocker and Bjorkquist, [@B40]; Crandall and O\'Brasky, [@B8]; DeGrado et al., [@B9]; Sanyal et al., [@B43]; Baird et al., [@B3]; Shingles and Moroney, [@B46]; Wang et al., [@B52]). These early reports had in common the mixing of two solutions having dissimilar CO~2~/$\text{HCO}_{3}^{-}$/pH status, and the monitoring of the subsequent time course of at least one parameter from a pH-sensitive dye. Except for one case (Shingles and Moroney, [@B46]), these earlier papers provided only rudimentary experimental detail, raising the concern that at least one of the two initial solutions had a pH sufficiently extreme as to be incompatible with living cells. Later investigators introduced CA assays based on continuous-flow calorimetry (Kernohan and Roughton, [@B28]), the release of ^14^CO~2~ (Stemler, [@B49]), and the exchange of ^18^O-labeled CO~2~/$\text{HCO}_{3}^{-}$ as measured by mass spectrometry (Itada and Forster, [@B21]). Although the authors\' main objective in the ^18^O-exchange study was to measure the CA activity of intact RBCs, they recognized that their assay is very sensitive to small degrees of CA released by hemolysis. Nevertheless, none of these approaches is easily translated to a SF platform as a method for assessing hemolysis in real time.

Here, we describe novel methods for assaying CA activity in a SF device, and then extending these assays to assess RBC hemolysis. Our CA assay exploits earlier work from our laboratory to generate out-of-equilibrium (OOE) CO~2~/$\text{HCO}_{3}^{-}$ solutions (Zhao et al., [@B56]) with virtually any combination of \[CO~2~\], \[$\text{HCO}_{3}^{-}$\], and pH, even somewhat beyond the pathophysiological range of values. In the present study, we combine two dissimilar CO~2~/$\text{HCO}_{3}^{-}$ solutions---solution (A) 0% CO~2~/0 $\text{HCO}_{3}^{-}$/pH 7.03 and solution (B) 1% CO~2~/44 mM $\text{HCO}_{3}^{-}$/pH 8.41---to create in the reaction cell of an SF device a predetermined initial OOE state---0.5% CO~2~/22 mM $\text{HCO}_{3}^{-}$/pH \~7.25---in which the pH is far too low for the predetermined \[CO~2~\]/\[$\text{HCO}_{3}^{-}$\] ratio. Thus, the system spontaneously undergoes the reactions $\text{HCO}_{3}^{-} + \text{H}^{+}\overset{\text{rapid}}{\rightarrow}\text{H}_{2}\text{CO}_{3}\overset{\text{slow}}{\rightarrow}\text{CO}_{2} + \text{H}_{2}\text{O},$ causing pH in the SF reaction cell to rise to \~7.50. Because CA catalyzes the reaction $\text{HCO}_{3}^{-} + \text{H}^{+}\overset{\text{CA}}{\rightarrow}\text{CO}_{2} + \text{H}_{2}\text{O},$ (effectively bypassing the slow H~2~CO~3~ dehydration), we can use the time course of pH, reported by the fluorescent dye pyranine (also known as HPTS for 8-hydroxypyrene-1,3,6-trisulfonic acid, trisodium salt) or the non-fluorescent dye phenol red, to compute CA activity. We validate this technique on purified bovine CA II (bCAII) and hemolysates of mouse blood, and then apply it to ostensibly intact murine RBCs, where we find that the actual hemolysis is \~4.9%. Given the sensitivity, precision, and ease of our methodology, this approach could be valuable for assessing CA release (i.e., lysis) from virtually any membrane-bound structure during SF experiments, or for detecting CA release from fluid that was previously in contact with living cells.

Materials and methods {#s2}
=====================

Ethical approval
----------------

Protocols for housing and handling of mice were approved by the Institutional Animal Care and Use Committee at Case Western Reserve University.

Solutions
---------

The compositions of solutions are shown in Table [1](#T1){ref-type="table"}. For the CA assay, we combined solution A with solution B in the SF device to obtain the initial OOE solution ("Mix") in the reaction cell. To achieve the desired pH, we titrated solutions with NaOH or HCl either at room temperature (RT, for RBC washing solution) or at 10°C (for pH calibration solution and OOE A and B solutions). pH measurements were recorded on a portable pH meter (model A121 Orion Star, Thermo Scientific, Beverly, MA) fitted with a pH electrode (Ross Sure-Flow combination pH Electrode, Thermo Scientific) at RT or at 10°C. For all work at 10°C---both pH titration of solutions and the actual experiments---we used a refrigerated, constant-temperature, shaker water bath (model RWB 3220, Thermo Fisher Scientific Inc., Asheville, NC) and several Telesystem magnetic stirrers (Thermo Fisher Scientific). Beakers containing the pH calibration buffers (pH at 6, 8, and 10, Fisher Scientific, Fair Lawn, NJ), the solutions to be titrated, and the pH electrode in its storage solution (Beckman Coulter, Inc. Brea, CA) were equilibrated, as appropriate, at either RT or 10°C. Osmolality was measured using a vapor pressure osmometer (Vapro 5520; Wescor, Inc., Logan, UT), and adjusted upward if necessary by the addition of NaCl.

###### 

**Physiological solutions**.

  **Component or parameter**                          **RBC washing solution**                  **pH calibration solution for pyranine**   **OOE solution for CA assay with pyranine**   **pH calibration solution for phenol red**   **OOE solution for CA assay with Phenol Red**                                                                                                                        
  --------------------------------------------------- ----------------------------------------- ------------------------------------------ --------------------------------------------- -------------------------------------------- ----------------------------------------------- -------------------------------------- -------------------------------------- -------------------------------------- ---------
  NaCl (mM)                                           92.5                                      150                                        140                                           116                                          128                                             151                                    142                                    116                                    128
  KCl (mM)                                            0                                         3                                          3                                             3                                            3                                               3                                      3                                      3                                      3
  CaCl~2~ (mM)                                        0.01                                      1                                          2                                             0                                            1                                               1                                      2                                      0                                      1
  Na~2~HPO~4~ (mM)[^\*^](#TN1){ref-type="table-fn"}   46.98                                     0                                          0                                             0                                            0                                               0                                      0                                      0                                      0
  NaH~2~PO~4~ (mM)[^\*^](#TN1){ref-type="table-fn"}   11.02                                     0                                          0                                             0                                            0                                               0                                      0                                      0                                      0
  HEPES (mM)[^†^](#TN2){ref-type="table-fn"}          0                                         8                                          16                                            0                                            8                                               7                                      14                                     0                                      7
  NaHCO~3~ (mM)[^‡^](#TN3){ref-type="table-fn"}       0                                         0                                          \~0                                           44                                           22                                              0                                      \~0                                    44                                     22
  CO~2~ (%)                                           0                                         0                                          \~0                                           \~1                                          0.5                                             0                                      \~0                                    \~1                                    0.5
  pH                                                  \~7.40[^\*^](#TN1){ref-type="table-fn"}   7.50[^†^](#TN2){ref-type="table-fn"}       7.03[^†^](#TN2){ref-type="table-fn"}          8.41[^‡^](#TN3){ref-type="table-fn"}         \~7.25                                          7.50[^†^](#TN2){ref-type="table-fn"}   7.03[^†^](#TN2){ref-type="table-fn"}   8.41[^‡^](#TN3){ref-type="table-fn"}   \~7.30
  Pyranine (μM)[^§^](#TN4){ref-type="table-fn"}       0                                         1 or 0                                     0                                             2 or 0                                       1 or 0                                          0                                      0                                      0                                      0
  Phenol red (mM)[^§^](#TN5){ref-type="table-fn"}     0                                         0                                          0                                             0                                            0                                               1 or 0                                 0                                      2 or 0                                 1or 0
  bCAII, lysate, RBCs                                 0                                         0                                          ++ or 0                                       0                                            \+ or 0                                         0                                      ++ or 0                                0                                      \+ or 0
  ACZ                                                 0                                         0                                          0                                             ++ or 0                                      \+ or 0                                         0                                      0                                      0                                      0
  Temperature (°C)                                    RT                                        10                                         10                                            10                                           10                                              10                                     10                                     10                                     10
  Osmolality (mOsm)                                   \~300                                     \~295                                      \~295                                         \~300                                        \~298                                           \~295                                  \~295                                  \~300                                  \~298

*The ratio \[$\text{HPO}_{\textit{4}}^{=}$\]/\[H~2~$\text{PO}_{4}^{-}$\] determines the pH at RT (\~22°C)*.

*For the pH calibration solution, we titrated HEPES free acid (pK \~7.5) to pH 7.50 with NaOH, and then in some aliquots added either HCl or more NaOH to achieve pH-values from 5.50 to 8.50 at 10°C. After the titration, we added pyranine or phenol red to equal concentrations in each solution. For OOE solution A, we titrated HEPES free acid to pH 7. 03 with NaOH*.

*The addition of $\text{HCO}_{3}^{-}$ generates some CO~2~ and $\text{CO}_{3}^{=}$; this mixture determined the final pH at 10°C*.

*\[Pyranine\] was present at a concentration of 1 μM in the reaction cell (to obtain pH data) or 0 μM (to obtain background data)*.

*\[Phenol Red\] was present at a concentration of 1 mM in the reaction cell (to obtain pH data) or 0 mM (to obtain background data)*.

*The values in this pyranine column are those at the instant of mixing solutions A and B. The solution is out of equilibrium because the pH of 7.25 is far too low, given \[$\text{HCO}_{3}^{-}$\] = 22 mM and CO~2~ = 0.5%*.

*The values in this Phenol Red column are those at the instant of mixing solutions A and B*.

Stopped-flow fluorescence spectroscopy
--------------------------------------

### Data acquisition and analysis

We rapidly combined solutions A and B using the SX-20 stopped-flow apparatus (Applied Photophysics, Leatherhead, UK). We excited the pH-sensitive fluorescent dye pyranine (H348, Invitrogen, Eugene, OR, USA; see Avnir and Barenholz ([@B2]) using an excitation wavelength of 460 nm (pH-sensitive wavelength), or of 415 nm (pH-independent isosbestic point), while monitoring total fluorescence emission using a 488 nm long-pass filter. The sampling period of the SF device was 12.5 μs. Because the output of the device was 1 data point every 0.1 s, each data point represents (10^−1^ s)/(12.5 × 10^−6^ s) = 8,000 samples. Our duration of data collection ranged from 20 s (i.e., 200 data points) for rapid reactions (i.e., high CA activity, A) to 200 s (i.e., 2000 data points) for slow reactions (e.g., the uncatalyzed reaction, where A = 1, the minimum value).

For each new experimental sample of solutions A and B (see Table [1](#T1){ref-type="table"}), we began by performing six SF shots to ensure that the new solutions were loaded into the reaction cell, and then sequentially acquired four time courses. First, we acquired two time courses in which solution B contained no dye (see Table [1](#T1){ref-type="table"}), one a time course of *I*~Background,\ 460~ during one stopped-flow shot while exciting at 460 nm, and then a time course of *I*~Background,\ 415~ during a second shot while exciting at 415 nm. Then we replaced solution B with one that had an identical composition except for the inclusion of dye (see Table [1](#T1){ref-type="table"}), performed six additional SF shots, and then acquired two time additional courses, one while exciting at 460 nm to yield *I*~Total,\ 460~, and another at 415 nm to yield *I*~Total,\ 415~. After correcting for background, we obtained for each experimental sample the time course of the ratio (*I*~460~/*I*~415~) = \[(*I*~Total,\ 460~ − *I*~Background,\ 460~)/(*I*~Total,\ 415~ − *I*~Background,\ 415~)\], which we converted to the time course of pH as described below. For some samples, solution B contained acetazolamide (see Table [1](#T1){ref-type="table"}). After each experimental sample---for which we acquired four sequential time courses as outlined above---we extensively flushed (2 × 2.5 ml in each syringe) both the "A" and "B" lines of the SF device with OOE "A" buffer (for the "A" line) or "B" buffer (for the "B" line). The exception was that we did not flush line "A" between samples in a sequence of ascending \[bCAII\] in **Figure 2**, or ascending RBC lysate in **Figure 3**.

### Calibration of dye

We chose pyranine (HPTS) as our fluorescent pH indicator because others have found it suitable for monitoring extracellular pH; its favorable properties include a low rate of permeation across cell membranes (Shingles and Moroney, [@B46]; Avnir and Barenholz, [@B2]; Han and Burgess, [@B16]). We calibrated the pH indicator dye pyranine at 10°C by mixing, in the SF device, two identical solutions that were either the pH-7.50 "pH calibration solution for pyranine" listed in Table [1](#T1){ref-type="table"}, or variants thereof obtained by titrating the pH as outlined in a footnote to Table [1](#T1){ref-type="table"}. For each pH-value X, we computed (*I*~460~/*I*~415~)~pHx~ as described in the previous section. Using an approach described previously for another pH-sensitive fluorophore (Boyarsky et al., [@B5]), we fitted the following theoretical titration curve to our experimental data:
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which normalizes the data to the value observed at pH 7.5, and forces the function to have a value of unity at this pH. Here, *b* is the difference between the maximal and minimal asymptotic values of (*I*~460~/*I*~415~)~pHx~/(*I*~460~/*I*~415~)~7.5~.

We used an iterative, non-linear least-squares method (Boyarsky et al., [@B5]) to determine *b* and pK. Figure [1A](#F1){ref-type="fig"} shows a plot of the data from five sets of experiments, as well as the best-fit curve. The best-fit values were 7.11 ± 0.01 (*SD*) for the pK, and 1.39 ± 0.01 (*SD*) for *b*. We used these values of pK and *b*---obtained at 10°C---and the values for ratio of (*I*~460~/*I*~415~) in each experiment to calculate pH. Others have reported pK-values for pyranine of 7.24 at RT (Avnir and Barenholz, [@B2]) and \~7.3 at 25°C (Han and Burgess, [@B16]).

![**Calibration of pH-sensitive dyes at 10°C. (A)** Dependence of normalized fluorescence-excitation ratio of pyranine on pH. For each data point at one of 16 pH-values (pH~x~), we record the time course of fluorescence emission (≥488 nm) in the stopped-flow device separately at excitation wavelengths of 460 and 415 nm, first in the absence and then in the presence of dye, and obtain the background-subtracted ratio (I~460~/I~415~)~pHx~, as described in Section Materials and Methods. We then divide each (I~460~/I~415~)~pHx~ by the value observed at pH 7.50 in that experiment to obtain the normalized fluorescence-excitation ratio (I~460~/I~415~)~pHx~/(I~460~/I~415~)~pH7.5~. The value 7.11 is the best-fit value for pK, and 1.39 is the best-fit value for the difference between the maximal and minimal asymptotic values of (*I*~460~/*I*~415~)~pH~x~~/(*I*~460~/*I*~415~)~7.5~. The data are from five sets of experiments. **(B)** Dependence of normalized absorbance ratio of phenol red on pH. For each data point at one of 12 pH-values (pH~x~), we record absorbance separately at the pH-sensitive wavelength of 570 nm and at the isosbestic wavelength of 480 nm. After subtracting the background at each incident wavelength, we obtain the ratio (A~570~/A~480~)~pHx~. We then normalize each (A~570~/A~480~)~pHx~ to the value observed at pH 7.50 in that experiment, as described in Section Materials and Methods. The data are from five sets of experiments. In both **(A,B)**, we show each individual point, some of which overlie other. *N* is the number of experiments in each experiment, we obtained data for each pH. The curves through the points---and the pK and *b*-values (±*SD*)---are the result of non-linear least-squares calculations.](fphys-08-00169-g0001){#F1}

Stopped-flow absorbance spectroscopy
------------------------------------

### Data acquisition and analysis

Using an approach similar to that outlined above for stopped-flow fluorescence spectroscopy, we used stopped-flow absorbance spectroscopy with the non-fluorescent pH-sensitive dye phenol red (P4633, Sigma-Aldrich, St. Louis, MO) to record absorbance at wavelengths of 570 nm (pH-sensitive wavelength) and 480 nm (pH isosbestic wavelength; Hollingworth and Baylor, [@B19]). The sampling period was 12.5 μs, and the duration of data collection ranged from 20 to 200 s.

For each experimental sample, we acquired two time courses in the absence of dye (Table [1](#T1){ref-type="table"}), *A*~Background,\ 570~ and *A*~Background,\ 480~, and also two time courses in the presence of dye (Table [1](#T1){ref-type="table"}), *A*~Total,\ 570~ and *A*~Total,\ 480~. For each experimental sample, we obtained the time course of the ratio (*A*~570~/*A*~480~) = \[(*A*~Total,\ 570~ − *A*~Background,\ 570~)/(*A*~Total,\ 480~ − *A*~Background,\ 480~)\], which we converted to the time course of pH as described below.

### Calibration of dye

We chose phenol red as our non-fluorescent pH indicator because others have found it suitable for long-term monitoring of pH in cell- or tissue-culture media. We calibrated the pH indicator phenol red at 10°C by mixing, in the SF device, two identical solutions that were either the pH-7.50 "pH calibration solution for Phenol red" listed in Table [1](#T1){ref-type="table"}, or variants thereof at different pH-values (see footnote to Table [1](#T1){ref-type="table"}). For each pH-value X, we computed (*A*~570~/*A*~480~)~pHx~, using an equation similar to that described above for pyranine:
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Figure [1B](#F1){ref-type="fig"} shows a plot of the data from five sets of experiments, as well as the best-fit curve. The best-fit values, obtained using an iterative, non-linear least-squares method (Boyarsky et al., [@B5]), were 7.61 ± 0.01 (*SD*) for the pK, and 2.45 ± 0.03 (*SD*) for *b*. We used these values of pK and *b*---obtained at 10°C---and the values for ratio of (*A*~570~/*A*~480~) in each experiment to calculate pH. Others have reported the pK of phenol red to be 7.67 at 25°C (Sendroy and Rodkey, [@B45]), and 7.73 at 16--17°C (Hollingworth and Baylor, [@B19]).

Carbonic anhydrase assay
------------------------

For some experiments, we obtained purified bCAII, isolated from erythrocytes (C2522, Sigma-Aldrich, St. Louis, MO), and resuspended it in 0.2% bovine serum albumin at a concentration of 1 mg/mL. We added varying amounts of bCAII to establish concentrations from 0.5 to 8 μg/mL in solution A (Table [1](#T1){ref-type="table"}). Rapid mixing with solution B (containing 2 μM pyranine) at 10°C in the SF reaction cell initiates the reactions $\left. \text{HC}\text{O}_{3}^{-} + \text{H}^{+}\rightarrow\text{H}_{2}\text{C}\text{O}_{3}\rightarrow\text{C}\text{O}_{2} + \text{H}_{2}\text{O and HC}\text{O}_{3}^{-} + \text{H}^{+}\overset{\text{CA}}{\rightarrow}\text{C}\text{O}_{2} + \text{H}_{2}\text{O}, \right.$ causing pH to rise exponentially. Under stopped-flow conditions, we exploited the fluorescence of pyranine to monitor this pH trajectory as described above. In other experiments, instead of adding bCAII to solution A, we added murine RBC lysate (described below), murine RBCs (described below), or mixtures of the two. In some of the lysate and RBC experiments, we instead exploited the absorbance of phenol red.

Regardless of the dye used, we fitted the pH time course with the equation
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where *t* is time, *A* is the final (equilibrated) value of pH, *B* is the pH range, and *k*~ΔpH~ is the rate constant of the pH relaxation. We obtained *A, B*, and *k*~ΔpH~ using a non-linear least-squares method.

Blood collection
----------------

Prior to blood collection, a 1-mL syringe and attached 23-gauge needle were rinsed with 0.1% sodium heparin (H4784, Sigma-Aldrich). Adult C57/BL6 wild type (WT) mice (8--16 weeks old) were sacrificed by cervical dislocation and blood was immediately collected by the cardiac-puncture method (Parasuraman et al., [@B35]) using the aforementioned syringe and needle. The blood was transferred to a 1.5-mL tube, centrifuged in a Beckman Microfuge 16 Microcentrifuge (Beckman, Brea, CA) at 600 × g for 10 min and the resulting supernatant \#0 and buffy coat were removed. To remove residual extracellular Hb, the pelleted RBCs were resuspended ("resuspended RBCs") in RBC washing solution (Table [1](#T1){ref-type="table"}) to a \~5--10% hematocrit (Hct), and centrifuged at 600 × g for 5 min. The supernatant from this centrifugation is supernatant \#1. This process was repeated 3×, with an estimation of percent hemolysis (see below) performed at each step. After these four washes, RBCs were resuspended in RBC washing solution to a final Hct of 25--30%, and maintained for up to \~5 h on ice for experiments performed that day.

We computed the Hb concentration, \[Hb\], using a novel least-square\'s approach, based on Beer\'s law. It is well-known that pure Hb has an absorbance at 650 nm (*A*~650~) of \~0 (Philo et al., [@B39]; Barlow et al., [@B4]; Hernández et al., [@B17]), and we found that *A*~650~ is likewise \~0 in RBC hemolysates (data not shown; preparation described in next section). When we compared absorbance spectra of ostensibly intact RBCs with those of RBC lysates of equal \[Hb\] value, we found that they were virtually identical except that the spectra for ostensibly intact RBCs were displaced upward by almost exactly *A*~650~ (not shown). Therefore, to compute \[Hb\]---regardless of whether we were dealing with samples of ostensibly intact RBCs or RBC lysate---we determined *A*~560~, *A*~576~, and *A*~650~ on a Beckman Coulter 730 Life Science UV/Vis Spectrophotometer (Beckman, Brea, CA), using the following equation (see following section for derivation):
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where *l* is the pathlength of 1 cm, the molar extinction coefficient for oxy-hemoglobin at 560 nm (ε~560~) is 32,613.2 cm^−1^ M^−1^, and ε~576~ is 55,540 cm^−1^ M^−1^ (Prahl, [@B41]).

After the initial centrifugation of whole blood, we estimated percent hemolysis after determining \[Hb\] in (a) the blood plasma (i.e., supernatant \#0; see definition, above), and (b) in the pelleted RBCs after their resuspension in RBC washing solution, using the equation:
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where *V* is volume. In **Figure 5A**, the resulting value is plotted as "Number of washes of RBCs" = 0.

After each step *i* of RBC washing, we estimated %*H* hemolysis by determining \[Hb\] in the supernatant \#*i* and the resuspended RBCs:
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where *V* is volume. In **Figure 5A**, the resulting values are plotted as "Number of washes of RBCs" = 1, 2, 3, and 4. Because a tiny fraction of RBCs may hemolyzed with each wash, the preceding equation may slightly underestimate the true %*H*.

Derivation of equation for hemoglobin concentration
---------------------------------------------------

According to the Beer-Lambert law, the hemoglobin concentration is \[Hb\] = *A*~λ~/ℓε~λ~, where *A*~λ~ is absorbance at wavelength λ, ℓ is pathlength (cm), and ε~λ~ is the molar extinction coefficient (cm^−1^ M^−1^).

To determine the concentration (*C*) from the following equation:
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we used a least-squares method. To avoid inaccuracies caused by dividing by ε, which varies substantially, consider
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In the present study, we obtain three absorbance values---*A*~560~ (560 nm is a local valley for oxygenated Hb), *A*~576~ (576 nm is a local peak), and *A*~650~ (650 nm is O~2~ independent)---from which we derive *A*~1~ = *A*~560~ − *A*~650~ and *A*~2~ = *A*~576~ − *A*~650~. Because each derived *A*-value has a corresponding ε-value, we have two data points (*A*~1~, ε~1~) and (*A*~2~, ε~2~). The objective of the least-squares method is to find the best-fit value of *C* that minimizes the value of the following function:
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Simulated hemolysis
-------------------

An RBC lysate was produced by osmotic lysis of 20 μL of freshly prepared, packed mouse RBCs (see above) in Milli-Q H~2~O (Milli-Q® Integral Water Purification System, EMD Millipore Corporation, Billerica, MA) of \~1:8 dilution, followed by centrifugation at 15000 × g for 5 min in a Beckman Microfuge 16 at RT. The supernatant (cleared of cellular debris) then was removed and the hemolysate was transferred to a clean 1.5 mL tube for a spectroscopic determination of \[Hb\] as described above.

We achieved simulated degrees of hemolysis (Table [2](#T2){ref-type="table"}, column 1), ranging from 0% (an apparent value) to 100% (an actual value) by combining different proportions of (a) freshly prepared, ostensibly intact RBCs (Table [2](#T2){ref-type="table"}, column 2) and (b) a lysate (representing 100% lysis; Table [2](#T2){ref-type="table"}, column 3), while maintaining the total \[Hb\] at 2.5 μM in the SF reaction cell.

###### 

**Establishing the fraction of apparent hemolysis**.

  **% Apparent hemolysis (%)**   **Intact RBCs[^\*^](#TN8){ref-type="table-fn"}(%)**   **RBC hemolysate[^\*^](#TN8){ref-type="table-fn"} (%)**
  ------------------------------ ----------------------------------------------------- ---------------------------------------------------------
  0                              100                                                   0
  5                              95                                                    5
  10                             90                                                    10
  25                             75                                                    25
  50                             50                                                    50
  100                            0                                                     100

*100% refers to 2.5 μM hemoglobin in the reaction cell*.

Analysis of data
----------------

We report results as mean ± *SD*. We analyze data using two-tailed unpaired student\'s *t*-test or two-tailed paired student\'s *t*-test, considering *P* \< 0.05 as significant. In **Figure 5A**, we also applied the Holm-Bonferroni correction for the 10 comparisons and using α = 0.05 (Holm, [@B20]).

Results {#s3}
=======

We developed a novel CA assay, based on the first use of out-of-equilibrium CO~2~/$\text{HCO}_{3}^{-}$ solutions in a stopped-flow device. OOE technology makes it possible to generate, for a brief period of time, solutions in which CO~2~, $\text{HCO}_{3}^{-}$ and H^+^ are predictably out of equilibrium, even though each of their concentrations may have near-physiological values (Zhao et al., [@B56]). We use the fluorescent dye pyranine and SF fluorescence spectroscopy for most of our analyses. However, in some experiments, we use the dye phenol red and SF absorbance spectroscopy. We choose an SF temperature of 10°C to match the condition of our parallel O~2~ study, and at the same time maintain a suitable CA catalytic rate. We choose the pH to be \~7.25 at the instant of mixing in the SF reaction cell. Over the ensuing seconds, the net reaction $\text{HCO}_{3}^{-}$ + H^+^ → CO~2~ + H~2~O causes pH to rise exponentially to \~7.50. We estimate[^1^](#fn0001){ref-type="fn"} that, during this time, \[$\text{HCO}_{3}^{-}$\] falls from 22.0 to 21.16 mM, and that \[CO~2~\] rises by the same amount, from 0.23 mM (i.e., 0.5% CO~2~) to 1.06 mM. Because the Hct in the SF reaction cell is \~0.15% (see below), any traffic of CO~2~ or $\text{HCO}_{3}^{-}$ across the RBC membrane would have only trivial effects on extracellular composition. We assume that changes in intracellular composition would not affect the degree of hemolysis.

CA assay on purified bovine CA II
---------------------------------

First, we test our CA assay on purified bCAII, over a range of \[bCAII\] values. The pyranine dye is in the syringe opposite to the one containing bCAII (Table [1](#T1){ref-type="table"}). With no added CA (0 μg/ml), pH rises very slowly, reaching \~7.50 in \~200 s (Figure [2A](#F2){ref-type="fig"}, lowest curve). As we increase the bCAII concentration in the SF reaction cell (i.e., \[bCAII\]~RxCell~ = 0.25, 0.5, 1, 2, and 4 μg/ml), the equilibration speeds greatly. Figure [2B](#F2){ref-type="fig"} shows the same data as in Figure [2A](#F2){ref-type="fig"}, but over the first 5 s. For each \[bCAII\] in Figures [2A,B](#F2){ref-type="fig"} ---and many other similar experiments---we calculate the rate constant of the pH relaxation, using a least-squares approach to fit an exponential curve to each set of (pH, *t*) coordinates that describes the exponential increase in pH over time. Figure [2C](#F2){ref-type="fig"} summarizes the dependence of the rate constant *k*~ΔpH~ on \[bCAII\] at 10°C, and shows that graded increases in \[bCAII\] cause *k*~ΔpH~ to rise linearly. The y-intercept of the line of best fit, 0.0185 s^−1^, is the rate constant of the uncatalyzed chemical reactions that occur during the pH relaxation. The slope of the line, 0.8143 (s^−1^)/(μg/ml), is a measure of the specific activity of the bCAII.

![**CA assays on purified bovine CA II. (A)** Time courses of pH from 0 to 200 s, for concentrations of bCAII ranging from 0 to 4 μg/ml in the reaction cell. We added bCAII to solution A (Table [1](#T1){ref-type="table"}) and derived pH-values from the fluorescence of pyranine, added to solution B. **(B)** Time courses from 0 to 5 s, representing the same records as in **(A)**. **(C)** Dependence of the rate constant of the pH change on \[bCAII\]~RxCell~. We obtained *k*~ΔpH~-values from non-linear least-squares curve fits of data like those in **(A,B)**. **(D)** Effect of acetazolamide on time courses of pH from 0 to 200 s for \[bCAII\]~RxCell~ ranging from 0 to 4 μg/ml. These experiments are like those in **(A)**, except that we added 20 μM ACZ to solution B (Table [1](#T1){ref-type="table"}). **(E)** Time courses from 0 to 5 s, representing the same records as in **(D)**. **(F)** Dependence of *k*~ΔpH~ on \[bCAII\]~RxCell~ in the presence of ACZ. Each data point represents mean ± *SD* (error bar not shown if smaller than the symbol). *N* represents the number of independent experiments, each covering six concentrations (0--4 μg/ml).](fphys-08-00169-g0002){#F2}

Next, we studied the effect of CA blocker acetazolamide (ACZ) on bCAII enzymatic activity, adding ACZ to the syringe opposite to the one containing bCAII (Table [1](#T1){ref-type="table"}) to achieve a \[ACZ\]~RxCell~ in the reaction cell of 10 μM. Figures [2D,E](#F2){ref-type="fig"}, as expected, show that ACZ virtually collapses all the pH relaxations for the bCAII experiments (0.25--4 μg/ml) onto the curve describing no added bCAII. The summary in Figure [2F](#F2){ref-type="fig"} shows that, over the entire range of \[bCAII\] values, ACZ reduces *k*~ΔpH~ to nearly the uncatalyzed value.

CA assay on mouse RBC hemolysate
--------------------------------

Second, we extend our work to murine RBC lysates to determine if our CA assay can quantitate hemolysis. The pyranine dye is in the syringe opposite to the one containing RBC lysate (Table [1](#T1){ref-type="table"}). Figures [3A,B](#F3){ref-type="fig"} shows six pH trajectories, similar to those in Figures [2A,B](#F2){ref-type="fig"} except that here (Figures [3A,B](#F3){ref-type="fig"}) we replace bCAII with lysate from WT mouse RBCs. A percent lysate (%L) of 100% refers to hemolysate containing 2.5 μM Hb (i.e., Hct ≅0.15%) in the SF reaction cell; a %L of 50% refers to half this concentration of hemolysate (diluted in saline), and so on. In the absence of RBC lysate (i.e., %L = 0% in Figures [3A,B](#F3){ref-type="fig"}), pH rises from \~7.25 to reach \~7.50 at a low rate that is similar to what we saw above in Figures [2A,B](#F2){ref-type="fig"}. Here in Figures [3A,B](#F3){ref-type="fig"}, we see that increasing %L greatly speeds the equilibration of pH. Figure [3C](#F3){ref-type="fig"} summarizes the best-fit *k*~ΔpH~ data from a total of nine mice. As expected, *k*~ΔpH~ has a linear dependence on %L, and the y-intercept of \~0.0183 s^−1^ is nearly identical to the corresponding value in Figure [2C](#F2){ref-type="fig"}.

![**CA assays on lysate from mouse RBCs. (A)** Time courses of pH from 0 to 200 s, for different relative amounts of hemolysate. We added RBC lysate to solution A (Table [1](#T1){ref-type="table"}) and derived pH-values from the fluorescence of pyranine, added to solution B. We created all solutions by mixing different ratios of 100% RBC lysate (%L = 100%) and saline. %L = 100% corresponds to \~2.5 μM hemoglobin in the reaction cell. **(B)** Time courses from 0 to 5 s, representing the same records as in **(A)**. **(C)** Dependence of the rate constant of the pH change on the relative amount of RBC lysate. We obtained *k*~ΔpH~-values from non-linear least-squares curve fits of data like those in **(A,B)**. **(D)** Effect of acetazolamide on time courses of pH from 0 to 200 s for %L ranging from 0 to 100%. These experiments are like those in **(A)**, except that we added 10 μM ACZ to solution B (Table [1](#T1){ref-type="table"}). **(E)** Time courses from 0 to 5 s, representing the same records as in **(D)**. **(F)** Dependence of *k*~ΔpH~ on %L in the presence of ACZ. Each data point represents mean ± *SD* (error bar not shown if smaller than the symbol). *N* represents the number of independent experiments, each covering six levels of percent RBC lysate (%L: 0--100%).](fphys-08-00169-g0003){#F3}

Figure [3D](#F3){ref-type="fig"} through *F* show that ACZ, at a \[ACZ\]~RxCell~ of 5 μM, almost completely eliminates the CA activity of the hemolysate.

CA assay on mixtures of intact and hemolyzed mouse RBCs
-------------------------------------------------------

In a third set of experiments, we test our CA assay by creating a solution A (Table [1](#T1){ref-type="table"}) in which we combine, in different proportions: (a) freshly prepared, ostensibly "intact" RBCs (5 μM Hb, or \~0.3% Hct) with (b) a lysate from an equivalent mass of RBCs (5 μM Hb). Thus, in the SF reaction cell, after mixing with solution B, all solution A combinations generate a Hb concentration (\[Hb\]~RxCell~)---representing the sum of Hb both inside and outside the RBCs---of 2.5 μM. Thus, this approach simulates ostensible degrees of hemolysis between 0 and 100%, inclusive. Note that the total CA activity in the reaction cell---representing the sum of CAs both inside and outside the RBCs---is also constant across all RBC/lysate mixtures. The pyranine dye is in syringe B, opposite to the one containing the RBC/lysate mixture (Table [1](#T1){ref-type="table"}). Figures [4A,B](#F4){ref-type="fig"} show six pH trajectories obtained on blood from one mouse, and indicate that the greater the ratio of simulated RBC hemolysis the faster the equilibration of extracellular pH (pH~o~).

![**CA assays on mixtures of intact and hemolyzed RBCs. (A)** Time courses of pH from 0 to 200 s, for degrees of apparent percent hemolysis ranging from 0 to 100%. We added the hemolysate/RBC mixture to solution A (Table [1](#T1){ref-type="table"}) and derived pH-values from the fluorescence of pyranine, added to solution B. We created all solutions by mixing different ratios of 100% hemolysate and ostensibly 100% intact RBCs, so that the hemoglobin concentration in the reaction cell was always \~2.5 μM. **(B)** Time courses from 0 to 5 s, representing the same records as in **(A)**. **(C)** Dependence of the rate constant of the pH change on apparent percent hemolysis (App %*H*), which is inversely related to apparent percent intact RBCs (App %Int). We obtained *k*~ΔpH~-values from non-linear least-squares curve fits of data like those in **(A,B)**. **(D)** Effect of acetazolamide on time courses of pH from 0 to 200 s for apparent percent hemolysis ranging from 0 to 100%. These experiments are like those in (A), except that we added 10 μM ACZ to solution B (Table [1](#T1){ref-type="table"}). **(E)** Time courses from 0 to 5 s, representing the same records as in **(D)**. **(F)** Dependence of *k*~ΔpH~ on apparent %*H* (inversely related to apparent percent intact RBCs) in the presence of ACZ. Each data point represents mean ± *SD* (error bar not shown if smaller than the symbol). *N* represents the number of independent experiments, each covering six hemolysis/RBC mixtures (App %*H*: 0--100%, App %Int: 100--0%).](fphys-08-00169-g0004){#F4}

Note that an ostensibly 0% hemolysis (lowest pH records in Figures [4A,B](#F4){ref-type="fig"}) produces an equilibration that is considerably faster than the truly uncatalyzed pH trajectories (i.e., the lowest pH records) in Figures [2A,B](#F2){ref-type="fig"}, [3A,B](#F3){ref-type="fig"}. Thus, ostensibly 100% intact RBCs must, in fact, be partially hemolyzed in the SF reaction cell. Figure [4C](#F4){ref-type="fig"} summarizes the best-fit *k*~ΔpH~ data from a total of nine mice---the same nine mice as in Figure [3C](#F3){ref-type="fig"}. The *k*~ΔpH~ vs. percent hemolysis relationship is linear, as in Figures [2C](#F2){ref-type="fig"}, [3C](#F3){ref-type="fig"}. However, in Figure [4C](#F4){ref-type="fig"}, the y-intercept---the *k*~ΔpH~ of ostensibly 100% intact RBCs from WT mice---is \~0.0820 s^−1^. This value is more than 4-fold higher than the corresponding *k*~ΔpH~ in Figures [2C](#F2){ref-type="fig"}, [3C](#F3){ref-type="fig"}, confirming the partial lysis of these cells in the SF reaction cell.

Figures [4D,E](#F4){ref-type="fig"} show that ACZ, added to the syringe opposite to the one containing the RBC/lysate to achieve a \[ACZ\]~RxCell~ of 5 μM, almost completely eliminates the CA activity of the mixtures, across the entire range of simulated ostensible hemolysis. Figure [4F](#F4){ref-type="fig"} shows that, for all mixtures, ACZ reduces *k*~ΔpH~ to nearly the uncatalyzed value. The y-intercept in Figure [4F](#F4){ref-type="fig"}, which represents the near-fully uncatalyzed state, is only \~21% of the value observed in Figure [4C](#F4){ref-type="fig"}. Because the pyranine dye and the ACZ first make contact with the RBC/lysate in the SF reaction cell, the dye presumably reports---and the ACZ presumably slows---only the pH equilibration in the extracellular space, and not inside intact RBCs. Thus, the y-intercept in Figure [4C](#F4){ref-type="fig"} (which represents *k*~ΔpH~ for the uncatalyzed reaction + CA from lysed RBCs) and the y-intercept in Figure [3C](#F3){ref-type="fig"} (which represents *k*~ΔpH~ for the uncatalyzed reaction only) provide the information needed to compute hemolysis in the SF cell.

Assessing RBC hemolysis before and during SF experiments
--------------------------------------------------------

In a fourth set of experiments, we collect fresh whole blood from nice mice---the same nice mice as in Figures [3C](#F3){ref-type="fig"}, [4C](#F4){ref-type="fig"}---and obtain an initial hemolysis of 2.36 ± 1.04% before any washing (Figure [5A](#F5){ref-type="fig"}, number of washes = 0). We then wash the RBCs four times in RBC washing solution (Table [1](#T1){ref-type="table"}), obtaining the percent hemolysis after each step. After the fourth wash, we arrive at a hemolysis of 0.37% ± 0.21% (which is significantly \>0; *P* = 0.00013) before putting the RBCs into the SF device (Figure [5A](#F5){ref-type="fig"}). Our %*H*-value of 0.37%, which may slightly underestimate the true value as noted in Section Materials and Methods, is similar to the level of 0.5% reported by Itada and Forster in their ^18^O study (Itada and Forster, [@B21]).

![**Assessing RBC hemolysis. (A)** Estimation of the effect of RBC washes (before stopped-flow experiments) on hemolysis, starting with whole blood containing ostensibly 100% intact RBCs. Our approaches for computing percent hemolysis before the first wash or after wash \#*i* (*i*: 1--4) are described in Section Materials and Methods under "Blood collection." **(B--D)** Calculation of actual percent hemolysis of ostensibly 100% intact RBCs during a SF experiment. In **(B)**, we plot the dependence of the rate constant of pH relaxation on actual hemolysis, the latter being represented by increasing mixing ratios of RBC lysate to saline in Figure [3C](#F3){ref-type="fig"}. Here, *k*~uncat~ represents the uncatalyzed rate constant (i.e., *k*~ΔpH~ without CA), *k*~RBC,\ Lysate~ represents *k*~ΔpH~ in the presence of 100% lysate \[with (hemoglobin) ≅ 2.5 μM\], and *k*~cat,\ max~ represents the portion of *k*~RBC,\ Lysate~ due to the maximally catalyzed CA reaction. That is, *k*~cat,\ max~ = *k*~RBC,\ Lysate~ -- *k*~uncat~. In **(C)**, we plot the dependence of *k*~ΔpH~ on apparent hemolysis, the latter being represented increasing mixing ratios of RBC lysate to ostensibly 100% intact RBCs in Figure [4C](#F4){ref-type="fig"}. Here, *k*~RBC,\ OstInt~ represents *k*~ΔpH~ in the presence of ostensibly 100% intact RBCs, and *k*~cat,\ min~ represents the portion of *k*~RBC,\ OstInt~ due to the minimally catalyzed CA reaction (i.e., that due to the small amount of CA activity released from hemolyzed RBCs in the population of ostensibly 100% intact RBCs). That is, *k*~cat,\ min~ = *k*~RBC,\ OstInt~ − *k*~uncat~. In **(D)**, we overlay the plots in **(B,C)**. The percent hemolysis (%*H*) of RBCs during an SF experiment is the quotient *k*~cat,\ min~/*k*~cat,\ max~. One may obtain the same answer graphically by following, first, the horizontal arrow from the *y*-axis and, then, the vertical arrow to %*H*. **(E)** Comparison of %*H* of ostensibly 100%-intact RBCs after four washes (i.e., before the SF experiment) and during SF experiments. The value for "after wash \#4" in **(E)** is the same as for *i* = 4 in **(A)** (nine mice). The value for "During SF" in **(E)** is the mean for the same nine mice. For each mouse, we obtained plots that were the equivalent of those in **(B)** through **(D)**, and computed a %*H* for that mouse. Each data point represents the mean ± *SD* (lower error bar not shown if it overlaps with *x*-axis tick mark). Differences are evaluated using the two-tailed paired student\'s *t*-test. In **(A)**, \*indicates statistical significance---after applying the Holm-Bonferroni correction---for comparisons to wash \#0 of wash \#1 (*P* = 0.0013), wash \#2 (*P* = 0.00016), wash \#3 (*P* = 8.4 × 10^−5^), and wash \#4 (*P* = 7.2 × 10^−5^). None of the other comparisons in (**A)** yielded statistical significance. *N* represents the number of mice from which we obtained blood.](fphys-08-00169-g0005){#F5}

Figures [5B--D](#F5){ref-type="fig"} show our approach for determining RBC hemolysis in the SF reaction cell. We first determine the relationship between *k*~ΔpH~ and the percent actual hemolysis in an experiment like that in Figure [3C](#F3){ref-type="fig"}, in which we combine RBC lysate with saline in various proportions. The ascending light blue line in Figure [5B](#F5){ref-type="fig"} is the idealized result of such an experiment, and leads to two of the three rate constants needed for the calculation of %*H*. The brown circle at 0% actual hemolysis (i.e., 100% pure saline), represents the uncatalyzed rate constant (*k*~uncat~) as the overall reaction $\text{HCO}_{3}^{-}$ + H^+^ → CO~2~ + H~2~O approaches equilibrium under the conditions of our experiments. The red circle at 100% actual hemolysis (i.e., 100% RBC lysate), represents the rate constant (*k*~RBC,\ Lysate~) of the overall dehydration reaction, both uncatalyzed and catalyzed by the all of the CA released from our sample of RBC lysate (i.e., the \[CA\] corresponding to an \[Hb\] of \~2.5 μM). The difference between *k*~RBC,\ Lysate~ (horizontal red dashed line) and *k*~uncat~ (horizontal brown dashed line) represents the rate constant (*k*~cat,\ max~) of that portion of the overall reaction catalyzed by all the CA present in our sample of RBCs.

The ascending dashed magenta line in Figure [5C](#F5){ref-type="fig"} is the idealized result of an experiment like that in Figure [4C](#F4){ref-type="fig"}, in which we combine ostensibly intact RBCs with pure RBC lysate in various proportions. Figure [5C](#F5){ref-type="fig"} leads to the third rate constant needed for the calculation of percent hemolysis. The green circle at 0% apparent hemolysis (i.e., 100% ostensibly intact RBCs), represents the rate constant (*k*~RBC,\ OstInt~) of the overall dehydration reaction, both uncatalyzed and catalyzed by the CA released from the small fraction of RBCs that---unbeknownst to us---are hemolyzed at the time the material is inside the SF reaction cell. The difference between *k*~RBC,\ OstInt~ (horizontal green dashed line) and *k*~uncat~ (horizontal brown dashed line) represents the rate constant (*k*~cat,\ min~) of the portion of the overall reaction catalyzed by that small amount of CA released from ostensibly intact RBCs.

Finally, in Figure [5D](#F5){ref-type="fig"}---a superimposition of Figures [5A,B](#F5){ref-type="fig"}, we see the graphical approach for computing the percent actual hemolysis in the SF reaction cell. Starting from the blue circle on the *y*-axis, we move to the right (blue arrow) until we reach the origin of the magenta dashed line, and then move downward (blue arrow) to read the percent actual hemolysis off the light blue *x*-axis. Mathematically, this value is simply *k*~cat,\ min~/*k*~cat,\ max~. Using the approach in Figures [5B--D](#F5){ref-type="fig"}, we calculate that, even if we start with washed RBCs that are only \~0.37% hemolyzed before they enter the SF device (see above), the total hemolysis is 4.93% ± 1.67% (*SD*) in the SF reaction cell at the end of the experiment (Figure [5E](#F5){ref-type="fig"}). Thus, the process of performing the SF experiment---loading the RBC mixture into the SF syringes, the flow down the tubing, and the rapid mixing in the SF reaction cell---increases hemolysis.

Comparing RBC hemolysis using fluorescence vs. absorbance spectroscopy
----------------------------------------------------------------------

Lastly, we evaluate an alternative approach in which we replace stopped-flow fluorescence spectroscopy (using the dye pyranine) with stopped-flow absorbance spectroscopy (using the dye phenol red). We compare the CA-assay results---fluorescence vs. absorbance---for hemolysis on blood from three mice. As summarized in Figure [6](#F6){ref-type="fig"}, we find that the estimate of % hemolysis using the fluorescence approach with pyranine is indistinguishable from that that using the absorbance approach with phenol red.

![**Assessing hemolysis by fluorescence vs. absorbance spectroscopy**. Each *N* represents blood from one mouse, analyzed in parallel using both a fluorescence-based assay with pyranine and an absorbance-based assay with phenol red. Values are means ± *SD*, evaluated using a two-tailed paired student\'s *t*-test.](fphys-08-00169-g0006){#F6}

Discussion {#s4}
==========

Comparison of the present CA assay with previous kinetic studies
----------------------------------------------------------------

In the present paper, we describe a simple and rapid assay---based upon the release of CA from RBCs---for determining the degree of hemolysis of RBCs in a SF reaction cell. Moreover, the assay occurs over a time frame and under conditions that are very similar to those of other parallel experiments that generate SF data that are sensitive to percent hemolysis. These other parallel experiments include not only measurements of Hb-O~2~ saturation, but also other assays in which the release of a material (e.g., a pH-sensitive dye) previously inside the cell would confound the measurement. Our search of the literature does not identify previous methods for assessing %*H* in a SF reaction cell. Others have used the time course of light transmittance (a measure of light scattering) to assess relative hemolysis in assays of the osmotic fragility of RBCs (Didelon et al., [@B10]; Paździor et al., [@B38]; Górnicki, [@B15]). In this earlier approach, one can monitor slowly developing (over tens of seconds) changes in transmittance due to progressive hemolysis, but cannot assign a value to hemolysis *per se*.

In the present study, we obtain a single value of hemolysis measured over several tens of seconds, but cannot directly address the time course of hemolysis *per se*. However, because the time courses of pH in Figures [4A,B](#F4){ref-type="fig"} are exponential beginning no later than \~0.3 s after the stoppage of flow, we can conclude that the hemolysis was virtually complete by this time. In other words, the degree of hemolysis that we measure (right bar Figure [5E](#F5){ref-type="fig"}) presumably reflects the aggregate hemolysis that occurs to some extent in the preparation of the blood (left bar Figure [5E](#F5){ref-type="fig"}) but mainly in the syringes, tubing, and the first moments in the reaction cell of the SF device.

Others have previously assessed CA activity using pH-based SF approaches (Gibbons and Edsall, [@B12], [@B13]; Ho and Sturtevant, [@B18]; Kernohan, [@B26], [@B27]; Khalifah, [@B29]; Wistrand et al., [@B54]; Pocker and Bjorkquist, [@B40]; Crandall and O\'Brasky, [@B8]; DeGrado et al., [@B9]; Sanyal et al., [@B43]; Baird et al., [@B3]; Shingles and Moroney, [@B46]; Wang et al., [@B52]) with tissue homogenates or cell-free enzyme preparations. The ionic conditions in these earlier studies would have been inappropriate for living cells. By definition, these earlier studies involved monitoring pH as the solution in the SF reaction cell transitioned from an OOE state toward an equilibrium state. However, fundamental differences between our approach and those of others are that the present assay provides: Solutions A and B of moderate and defined pH-values. Regarding the previous SF studies of CA activity, only one (Shingles and Moroney, [@B46]) reports SF time courses of pH *per se*, and only one (Shingles and Moroney, [@B46]) provides sufficient detail (including pH-values of both solution A and solution B) to permit replication of the work. In our assay, both solution A (pH 7.03) and solution B (pH 8.41) have relatively moderate pH-values, thereby ensuring that the RBCs are under near-physiological electrolyte conditions throughout the assay. Even though the CA enzyme or RBCs are in the near-neutral solution A in our assay, it is important that solution B not have an extreme *p*-value. Earlier OOE work (Zhao et al., [@B56]) provided evidence of transient microdomains upon mixing of solutions A and B (i.e., the enzyme or cells in solution A could come into direct contact with relatively undiluted solution B). In principle, we could have designed a solution B with a lower pH. A consequence (all else being equal) would have been a smaller ΔpH during the relaxation phase of the experiment. However, the signal-to-noise resolution of our assays was sufficiently high that we could have still obtained reliable *k*~ΔpH~ data, even with a smaller ΔpH.Predictable pH-values in the SF reaction cell. Our OOE approach generates, upon mixing of solutions A and B, predictable pH-values at time zero, and predictable pH time courses (simulations not shown).

Although the assay in the present study is based on the reaction $\text{HC}\text{O}_{3}^{-} + \text{H}^{+}\overset{\text{CA}}{\rightarrow}\text{C}\text{O}_{2} + \text{H}_{2}\text{O}$ (equivalent to the dehydration of H~2~CO~3~) and thus produces a pH increase, we could have constructed solutions A and B so that, upon solution mixing in the reaction cell, the OOE state would have led to the opposite reactions (equivalent to the hydration of CO~2~) and thus a pH decrease.

Experiments at 10°C
-------------------

Transport events across the RBC membrane can be extremely fast. In the present study, we chose 10°C to match the temperature in parallel work on O~2~ fluxes. This temperature, although considerably less than typical physiological temperatures of mammals, is nevertheless higher than those used by other investigators in RBC-transport studies, where it is customary to lower RBC temperatures to 5°C or even 0°C (Kimzey and Willis, [@B30]; Lowe and Walmsley, [@B33]; Jensen et al., [@B23]; Jennings, [@B22]).

CAs in RBCs
-----------

The 14 mammalian α CAs (Sly and Hu, [@B47]; Purkerson and Schwartz, [@B42]; Supuran, [@B50]) are zinc-containing metalloenzymes that are expressed in virtually every cell of the body. They are broadly divided into four subgroups: the cytosolic \[a\] CA I, II, III, VII, and VIII; \[b\] the mitochondrial CA V; \[c\] the secreted CA VI; and \[d\] the membrane-bound CAs IV, IX, XII, and XIV (Sly and Hu, [@B47]; Parkkila et al., [@B36]; Karhumaa et al., [@B25]; Kummola et al., [@B31]; Scheibe et al., [@B44]). A proteomics study identified CA I, II, and III in RBC cytoplasm (Kakhniashvili et al., [@B24]). In human erythrocytes, CA II is a high-activity isozyme; CA I contributes only half of the total CA activity although it is almost six times as abundant as CA II (Khalifah, [@B29]; Dodgson et al., [@B11]; Sly and Hu, [@B47]). CA III---the activity of which is reported to be only 0.03--1% that of CA II (Sly and Hu, [@B47]; Purkerson and Schwartz, [@B42])---is expressed mainly in skeletal muscle and adipose tissue, but at lower levels in other tissues, including RBCs (Sly and Hu, [@B47]; Kakhniashvili et al., [@B24]; Pasini et al., [@B37]; Goodman et al., [@B14]). Within the RBC, these CA enzymes are critically important for converting metabolically produced $\text{C}\text{O}_{2}\text{ to HC}\text{O}_{3}^{-}(\text{C}\text{O}_{2} + \text{H}_{2}\text{O}\overset{\text{CA}}{\rightarrow}\text{HC}\text{O}_{3}^{-} + \text{H}^{+})$ while the RBC is in systemic capillaries, and then---after the RBC has transited to the lung---for reconverting the $\text{HC}\text{O}_{3}^{-}\text{ to  C}\text{O}_{2}(\text{HC}\text{O}_{3}^{-} + \text{H}^{+}\overset{\text{CA}}{\rightarrow}\text{C}\text{O}_{2} + \text{H}_{2}\text{O})$ in the pulmonary capillaries for elimination in the exhaled air.

Although a mass-spectrometry analysis study reveals no evidence of membrane-associated CAs in RBCs (Low et al., [@B32]), immunological and kinetic evidence points to a tiny amount of CA IV, presumably on the outer surface, that could contribute 0.2% of total CA activity (Wistrand et al., [@B55]). If this CA IV estimate for RBCs is correct, then 0.2/4.93% ≅ 4% of the estimated %*H* of 4.93% (Figure [5E](#F5){ref-type="fig"}) in the SF reaction cell could reflect the presence of extracellular-facing CA IV rather than hemolysis *per se* (i.e., we may slightly overestimate the degree of hemolysis).

Evidence for the validity of the present CA assay
-------------------------------------------------

The following analyses of our data provide evidence that our CA assay behaves in a stable and precise way:

1.  *Linear relationship of k*~Δ*pH*~ *vs. \[bCAII\]*. For the experiments in Figure [2](#F2){ref-type="fig"}, we chose a commercial preparation of bovine CA II, purified from RBCs, because bCAII is the most readily obtainable and reliable CA preparation. As expected, *k*~ΔpH~---which reflects the equilibration of all reactions as pH rises from \~7.25 to 7.50---rises linearly with increasing concentrations of CA II (Figure [2C](#F2){ref-type="fig"}). Thus, we hypothesized that we could exploit the release of CAs from RBCs to quantitate the degree of hemolysis.

2.  *Linear relationship of k*~Δ*pH*~ *vs. percent lysate*. For the experiments in Figure [3](#F3){ref-type="fig"}, we chose to work with the lysate of a preparation of mouse RBCs having a \[Hb\] of \~2.5 μM in the reaction cell---the starting material for the ostensibly intact RBCs in Figure [4](#F4){ref-type="fig"}. As expected, *k*~ΔpH~ in Figure [3C](#F3){ref-type="fig"} rises linearly with increasing %L (Figure [3C](#F3){ref-type="fig"}), reflecting the increasing concentration of CAs.

3.  *Linear relationship of k*~Δ*pH*~ *vs. percent hemolysis*. For the experiments in Figure [4](#F4){ref-type="fig"}, we dilute ostensibly intact RBCs with pure RBC lysate to maintain a \[Hb\] of \~ 2.5 μM in the reaction cell. Note that pyranine \[a\] permeates cell membranes poorly (Shingles and Moroney, [@B46]; Avnir and Barenholz, [@B2]; Han and Burgess, [@B16]) and \[b\] is in contact with the RBCs for only a few seconds. We find that pH~o~ rises with a near-exponential time course in Figures [4A,B](#F4){ref-type="fig"}, and that the resulting *k*~ΔpH~-values rise linearly with increasing %*H* (Figure [4C](#F4){ref-type="fig"}). If a substantial fraction of total pyranine were slowly entering RBCs (which undergo a pH decrease as CO~2~ enters and $\text{HCO}_{3}^{-}$ exits via AE1), the pH~o~ trajectory would have had a second phase that reflected the evolving contribution of the pH inside the RBCs. Thus, we can conclude that the CA inside the RBC is not appreciably accessible to the dye under the conditions of our experiments.

4.  *Consistency of 100% lysate/hemolysis points in* Figures [3C](#F3){ref-type="fig"}, [4C](#F4){ref-type="fig"}. In Figure [3C](#F3){ref-type="fig"}, the best-fit value for *k*~ΔpH~ when %L = 100% is 1.304 × 100% + 0.0183 = 1.322 s^−1^. In Figure [4C](#F4){ref-type="fig"}, the comparable value for *k*~ΔpH~ when %*H* = 100% is 1.249 × 100% + 0.0820 = 1.331 s^−1^. These two values differ by \< 0.7%, indicating the internal consistency of the two data sets.

5.  *CA activity of mouse RBCs*. From the previous paragraph, we see that the *k*~ΔpH~ in the 100% mouse RBC lysate (Figure [3C](#F3){ref-type="fig"}) is 1.322 s^−1^. From the line of best fit in Figure [2C](#F2){ref-type="fig"}, we see that a mouse RBC lysate value of 1.322 s^−1^ corresponds to a \[bCAII\]~RxCell~ of 1.6 μg/ml. Given a MW of 29,000 Da for bCAII, we calculate that the total CA activity (from mouse RBCs) in the reaction cell (representing 100% lysate) is equivalent to that of \~0.055 μM bCAII. Although we set mouse \[Hb\]~RxCell~ to 2.5 μM in Figure [3C](#F3){ref-type="fig"}, the mean corpuscular hemoglobin concentration (MCHC) for wild-type mouse RBCs that we obtained in a parallel study is 31.7 g/dL, which corresponds to a \[Hb\]~i~ of \~4.9 mM. Thus, the \[Hb\] in the reaction cell of the present study represents a \~1967-fold dilution of cytosolic Hb. We calculate that the total CA contributed by the mouse RBCs behaves as if it were \~109 μM bCAII. We are not aware of data on the CA content of mouse RBCs. However, the mean of three values for the CAII/Hb ratio of human RBCs (Tashian and Carter, [@B51]; Ali Akbar and Brown, [@B1]), together with an assumed \[Hb\]~i~ of 5 mM, leads to \[CAII\]~i~ of \~20 μM for human RBCs. Thus, our computed CA activity of mouse RBCs (equivalent to \~109 μM bCAII) is \~5-fold higher than the \[CAII\]~i~ of human RBCs. Considering that CAII contributes only about half of the total CA activity of human RBCs, and that the purchased bCAII may have a lower specific activity than the total CA released from freshly lysed mouse RBCs, we conclude that the equivalent concentration of \~109 μM bCAII is reasonable.

6.  *Consistency of slopes in* Figures [3C](#F3){ref-type="fig"}, [4C](#F4){ref-type="fig"}. As illustrated by the analysis in Figures [5B--E](#F5){ref-type="fig"}, the difference between the slopes of the best-fit lines in Figure [3C](#F3){ref-type="fig"} (i.e., 1.304 s^−1^/%L) and Figure [4C](#F4){ref-type="fig"} (i.e., 1.249 s^−1^/%*H*) is almost completely accounted for by the actual %Hemolysis of ostensibly intact RBCs (i.e., 4.93%). That is, 1.304 × 95.07% = 1.240, which is only \~0.7% lower than 1.249.

7.  *Comparison of y-intercepts in* Figures [3C](#F3){ref-type="fig"}, [4C](#F4){ref-type="fig"}. In Figure [3C](#F3){ref-type="fig"}, the best-fit value for the y-intercept (i.e., %L = 0%) is 0.0183 s^−1^, which is the rate constant for the uncatalyzed reactions. In Figure [4C](#F4){ref-type="fig"}, the comparable best-fit y-intercept is 0.0820 s^−1^, which is the aggregate *k*~ΔpH~ for the uncatalyzed and catalyzed reactions. The difference 0.0820 s^−1^ − 0.0183 s^−1^ = 0.0637 s^−1^, which represents the mean portion of *k*~ΔpH~ attributable to the extracellular CA activity of ostensibly intact RBCs. Dividing this residual y-intercept by the best-fit slope in Figure [3C](#F3){ref-type="fig"} yields the mean %*H* of ostensibly intact RBCs: (0.0637 s^−1^)/(1.304 s^−1^/%L) = 4.9%. Performing the computation mouse by mouse, we obtain 4.93 ± 1.67% (*N* = 9). The value, compared to the pre-SF value of 0.37 ± 0.21% indicates that a small amount of ostensibly intact RBCs are in fact hemolyzed in the SF reaction cell.

8.  *Effect of ACZ in* Figures [2D--F](#F2){ref-type="fig"}, [3D--F](#F3){ref-type="fig"}, [4D--F](#F4){ref-type="fig"}. In all of our studies, ACZ collapsed all pH trajectories to virtually the same time course---and the same pH range---as the uncatalyzed (i.e., slowest) reactions in Figures [2A--C](#F2){ref-type="fig"}, [3A--C](#F3){ref-type="fig"}. However, we notice that the best-fit y-intercepts in Figures [2F](#F2){ref-type="fig"}, [3F](#F3){ref-type="fig"}, [4F](#F4){ref-type="fig"} are all very slightly lower than those in Figures [2C](#F2){ref-type="fig"}, [3C](#F3){ref-type="fig"}. An analysis of the \[bCAII\]~RxCell~ = 0 points in Figure [2C](#F2){ref-type="fig"} (*k*~ΔpH~ = 0.0185 ± 0.0014 s^−1^) and Figure [2F](#F2){ref-type="fig"} (*k*~ΔpH~ = 0.0170 ± 0.0005 \[*SD*\] s^−1^) is a statistically significant difference (*P* = 0.028, two-tailed, unpaired *t*-test). For the %L = 0 points in Figure [3C](#F3){ref-type="fig"} (*k*~ΔpH~ = 0.0183 ± 0.0019 s^−1^) and Figure [3F](#F3){ref-type="fig"} (*k*~ΔpH~ = 0.0176 ± 0.0007 s^−1^), the difference is not statistically significant (*P* = 0.37, two-tailed, unpaired *t*-test). For the %*H* = 0 point in Figure [4F](#F4){ref-type="fig"}, *k*~ΔpH~ = 0.0170 ± 0.0006. Although it is possible that ACZ affects the pyranine dye, we suggest that it is more likely that, despite extensive washing between samples, a small amount of CA remains adsorbed to the surface of the reaction cell. Such a small amount of adsorbed CA would not affect our calculation of %*H* of ostensibly intact RBCs from a mouse because the uncatalyzed *k*~ΔpH~-value that we subtract is the value obtained in %L = 0 from an experiment like that in Figure [3B](#F3){ref-type="fig"} (not the one with ACZ in Figures [3E](#F3){ref-type="fig"} or [4E](#F4){ref-type="fig"}).

9.  *Phenol red vs. pyranine in* Figure [6](#F6){ref-type="fig"}. We observed that our novel CA/hemolysis assay---applied to the same murine RBC samples---yields virtually identical results with two different dyes, one studied by stopped-flow fluorescence and the other by stopped-flow absorbance spectroscopy. The absorbance-spectroscopy method with a non-fluorescent dye would be particularly useful when the system contains materials with significant fluorescence.

Conclusion {#s5}
==========

Our novel CA assay with OOE solutions makes it possible to assess hemolysis under approximately physiological conditions, and to do so over a predictable pH range. The increase in percent hemolysis between the time of loading samples into the SF machine (\< 0.4%) and during our SF assay (\~4.9%) presumably due to mechanical disruption of a subpopulation of susceptible RBCs during rapid mixing. This assay is easy to perform, highly sensitive and precise, and in principle could be implemented in either the direction $\text{HC}\text{O}_{3}^{-} + \text{H}^{+}\overset{\text{CA}}{\rightarrow}\text{C}\text{O}_{2} + \text{H}_{2}\text{O}$ (equivalent to H~2~CO~3~ dehydration, as in the present study) or the direction $\text{C}\text{O}_{2} + \text{H}_{2}\text{O}\overset{\text{CA}}{\rightarrow}\text{HC}\text{O}_{3}^{-} + \text{H}^{+}$ (equivalent to CO~2~ hydration). Moreover, it is readily amenable to miniaturization and automation using microfluidics. Applied to ostensibly intact RBCs, the assay could report RBC fragility and thus provide diagnostic insight in fresh blood from patients. Besides RBCs, the lysis assay could detect disruption within a SF device of many other cell types or membrane vesicles with entrapped CA. The underlying CA assay---applied to fluids such as blood plasma, tissue-culture media, and organ perfusates---could assess cell lysis in a wide range of cells or tissues previously in contact with these fluids. Applications could include quantitating RBC storage lesions before performing blood transfusions, evaluating the health of cells in culture or during flow cytometry, and assessing the health of organs for transplantation. Together with a panel of specific CA inhibitors, our assay also could quantitate multiple different CA subtypes within a sample, and identify the lysed cells from which they came.
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^1^We assumed that the system is closed for CO~2~/$\text{HCO}_{3}^{-}$, with initial \[CO~2~\] = 0.23 mM, initial \[$\text{HCO}_{3}^{-}$\] = 22 mM, pK = 6.2, and final pH = 7.50. The difference between the decrement in \[$\text{HCO}_{3}^{-}$\] and the increment in \[CO~2~\] is due to rounding errors.

App %*H*

:   apparent percent hemolysis

App %Int

:   apparent percent intact RBCs

\%*H*

:   percent hemolysis

%L

:   percent lysate

*k*~ΔpH~

:   the rate constant of pH relaxation

*k*~RBC,\ OstInt~

:   *k*~ΔpH~ in the presence of ostensibly 100% intact RBCs

*k*~RBC,\ Lysate~

:   *k*~ΔpH~ in the presence of 100% lysate

*k*~cat,\ max~

:   portion of *k*~RBC,Lysate~ due to the maximally catalyzed CA reaction

*k*~cat,\ min~

:   portion of *k*~RBC,OstInt~ due to the minimally catalyzed CA reaction

*k*~uncat~

:   uncatalyzed rate constant

RxCell

:   stopped-flow reaction cell.
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